MARCAN PHARMACEUTICALS INC. — Diltiazem Importer Profile
Pharmaceutical Importer · #3 buyer for Diltiazem · $2.6M import value · 99 shipments · CANADA · DGFT Verified
MARCAN PHARMACEUTICALS INC. is the #3 importer of Diltiazem from India with $2.6M in import value and 99 verified shipments. MARCAN PHARMACEUTICALS INC. holds a 9.0% market share in Diltiazem imports based in CANADA. The company sources from 1 verified supplier across 73 formulations shipped to 1 country. Overall, MARCAN PHARMACEUTICALS INC. imports 18 pharmaceutical products worth $21.9M across 9 therapeutic categories.
MARCAN PHARMACEUTICALS INC. — Diltiazem Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Diltiazem to MARCAN PHARMACEUTICALS INC.?
Verified from 99 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| EMCURE PHARMACEUTICALS LIMITED | $2.6M | 99 | 100.0% |
MARCAN PHARMACEUTICALS INC. sources Diltiazem from 1 verified Indian supplier based on 99 customs records. The primary supplier is EMCURE PHARMACEUTICALS LIMITED accounting for 100.0% of imports.
How Does MARCAN PHARMACEUTICALS INC. Compare to Nearest Diltiazem Importers?
Buyers ranked immediately above and below #3 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | EVERSANA LIFE SCIENCE SERVICES | UNITED STATES | $2.3M | 47 | $48.4K |
| 3 | MARCAN PHARMACEUTICALS INC. ★ | CANADA | $1.6M | 57 | $28.5K |
| 2 | TEVA PHARMACEUTICALS USA, INC | UNITED STATES | $1.4M | 27 | $50.0K |
| 4 | EVERSANA LIFE SCIENCES SERVICES,LLC | UNITED STATES | $1.1M | 22 | $50.0K |
MARCAN PHARMACEUTICALS INC. ranks #3 among 298 Diltiazem importers from India. Average shipment value of $28.5K compared to the market average of $38.9K. The closest competitors by value are EVERSANA LIFE SCIENCE SERVICES and TEVA PHARMACEUTICALS USA, INC.
Where Does MARCAN PHARMACEUTICALS INC. Import Diltiazem To?
Destination countries from 99 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $2.6M | 99 | 100.0% |
MARCAN PHARMACEUTICALS INC. imports Diltiazem to 1 country. The primary destination is CANADA receiving 100.0% of shipments worth $2.6M.
What Diltiazem Formulations Does MARCAN PHARMACEUTICALS INC. Import?
| Formulation | Value | Shipments |
|---|---|---|
| SANIS-DILTIAZEM CD CAP USP 180MG 100C-CA | $111.8K | 5 |
| SANIS-DILTIAZEM CD CAP USP 120MG 100C-CA | $104.6K | 4 |
| SANIS-DILTIAZEM CD CAP USP 240MG 100C-CA | $100.0K | 2 |
| MAR-DILTIAZEM T HCL ER 240MG 100C CA,BAT | $89.8K | 2 |
| MAR-DILTIAZEM T HCL ER 240MG 100C CA BATCH NO: H240880,H240881 | $76.6K | 3 |
| MAR-DILTIAZEM T HCL ER 180MG 100C CA BAT | $63.3K | 2 |
| MAR-DILTIAZEM T HCL ER 180MG 100C CA BATCH NO: H240888,H240889 | $63.2K | 3 |
| PHARMACEUTICAL PRODUCTS (FINISHED GOODS)- MAR-DILTIAZEM T HCL ER 180MG 100C CA | $59.3K | 2 |
| MAR-DILTIAZEM HYDROCHLORIDE CD CAPSULES | $58.4K | 2 |
| MAR-DILTIAZEM T HCL ER 120MG 100C CA BAT | $56.1K | 2 |
MARCAN PHARMACEUTICALS INC. imports 73 distinct Diltiazem formulations from India. The top formulation is SANIS-DILTIAZEM CD CAP USP 180MG 100C-CA with 5 shipments worth $111.8K.
Regulatory Requirements: Importing Diltiazem into Canada
What MARCAN PHARMACEUTICALS INC. and other importers must comply with to import Diltiazem from India
Regulatory Authority
Health Canada (HC)
Approval Process for Generic Diltiazem
Abbreviated New Drug Submission (ANDS) referencing an approved Canadian Reference Product. Comparative bioavailability study required.
Typical timeline: 12–18 months
GMP Requirements
Health Canada GMP (GUI-0001); on-site Drug Establishment Licence (DEL) inspection
Import Licence & Documentation
Drug Establishment Licence (DEL) for importer; Drug Identification Number (DIN) required
Labeling & Packaging
Bilingual (English/French) labeling required; Canadian format per Health Canada guidance
Note: Subject to C.01.014.6 annual review and Good Import Practices requirements.
Regulatory information is provided for general reference based on publicly available HC guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with HC or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Diltiazem from India and How Much Does MARCAN PHARMACEUTICALS INC. Import?
India exported $11.6M worth of Diltiazem through 1,820 shipments from 184 suppliers to 71 countries, serving 298 buyers globally. MARCAN PHARMACEUTICALS INC. imports $2.6M of this total, accounting for 9.0% of India's Diltiazem exports with 99 shipments from CANADA. This is verified from 99 customs shipment records covering 73 distinct formulations.
What Is the Average Order Value for MARCAN PHARMACEUTICALS INC.'s Diltiazem Imports?
MARCAN PHARMACEUTICALS INC.'s average Diltiazem order value is $26.1K per consignment, based on 99 shipments totaling $2.6M. MARCAN PHARMACEUTICALS INC. is based in CANADA and ranks #3 among all Diltiazem importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Diltiazem to MARCAN PHARMACEUTICALS INC.?
MARCAN PHARMACEUTICALS INC. sources Diltiazem from 1 verified Indian supplier: EMCURE PHARMACEUTICALS LIMITED ($2.6M, 100.0%). This is based on 99 customs records.
How Does MARCAN PHARMACEUTICALS INC. Compare to Other Diltiazem Importers?
MARCAN PHARMACEUTICALS INC. ranks #3 among 298 Diltiazem importers from India with a 9.0% market share. The top 3 importers are EVERSANA LIFE SCIENCE SERVICES ($2.3M), MARCAN PHARMACEUTICALS INC. ($1.6M), TEVA PHARMACEUTICALS USA, INC ($1.4M). MARCAN PHARMACEUTICALS INC. processed 99 shipments from CANADA.
What Other Cardiovascular Products Does MARCAN PHARMACEUTICALS INC. Import?
MARCAN PHARMACEUTICALS INC. also imports these cardiovascular products. Each links to the detailed product page.
About MARCAN PHARMACEUTICALS INC.
MARCAN PHARMACEUTICALS INC. imports 18 products worth $21.9M. Beyond Diltiazem, top products include Allopurinol, Ibuprofen, Ranitidine, Apixaban, Dapsone. View the complete MARCAN PHARMACEUTICALS INC. profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Diltiazem — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Diltiazem shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: MARCAN PHARMACEUTICALS INC. matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as MARCAN PHARMACEUTICALS INC.'s capped import value divided by total capped export value for Diltiazem across all Indian exporters.
- 5.Verified Records: This page is backed by 99 individual customs records matching MARCAN PHARMACEUTICALS INC. importing Diltiazem, covering 73 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 71+ countries, 298+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Diltiazem Import Data for MARCAN PHARMACEUTICALS INC.
Access order-level details, pricing data, supplier connections, and competitive analysis for MARCAN PHARMACEUTICALS INC.'s Diltiazem imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
MARCAN PHARMACEUTICALS INC.
Full Company Profile →
18 products · $21.9M total trade · 9 categories
MARCAN PHARMACEUTICALS INC. × Diltiazem
Verified from customs records
Company Overview
Top Products by MARCAN PHARMACEUTICALS INC.
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for MARCAN PHARMACEUTICALS INC..
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Diltiazem. For current order-level data, contact TransData Nexus.